ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.
about
ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells.MiR-29b/TET1/ZEB2 signaling axis regulates metastatic properties and epithelial-mesenchymal transition in breast cancer cells.FOXA2 promotes the proliferation, migration and invasion, and epithelial mesenchymal transition in colon cancer.Hypothesis: Cancer Is a Disease of Evolved Trade-Offs Between Neoplastic Virulence and Transmission.
P2860
ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.
@en
type
label
ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.
@en
prefLabel
ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.
@en
P2860
P356
P1433
P1476
ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.
@en
P2093
Darina Lazarova
Michael Bordonaro
P2860
P304
P356
10.7150/JCA.18762
P577
2017-05-12T00:00:00Z